| Dr Elizabeth Arbia, DO | |
|
110 Commerce Dr, Shelton, CT 06484-6244 | |
| (203) 929-7331 | |
| (203) 925-0330 |
| Full Name | Dr Elizabeth Arbia |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 110 Commerce Dr, Shelton, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225329238 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 052949 (Connecticut) | Primary |
| Entity Name | Griffin Faculty Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598755605 PECOS PAC ID: 7618871997 Enrollment ID: O20031120000158 |
News Archive
Marijuana use is on the rise, with an estimated 12.5 percent of adults living in the United States reportedly using the drug at least once in 2013, according to a new study that looked at drug usage over the span of a decade.
There are several forms of sunscreens that can be applied over the skin. These include those in the form of sprays, creams or lotions. However the Food and Drug Administration (FDA) has warned consumers that so-called sunscreen pills are fake and people should avoid such spurious claims.
Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
Dr. Reddy's Laboratories Ltd. today announced its unaudited financial results for the third quarter ended December 31, 2009 under International Financial Reporting Standards (IFRS).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Arbia, DO 67 Maple Ave, Derby, CT 06418-1328 Ph: (203) 732-1330 | Dr Elizabeth Arbia, DO 110 Commerce Dr, Shelton, CT 06484-6244 Ph: (203) 929-7331 |
News Archive
Marijuana use is on the rise, with an estimated 12.5 percent of adults living in the United States reportedly using the drug at least once in 2013, according to a new study that looked at drug usage over the span of a decade.
There are several forms of sunscreens that can be applied over the skin. These include those in the form of sprays, creams or lotions. However the Food and Drug Administration (FDA) has warned consumers that so-called sunscreen pills are fake and people should avoid such spurious claims.
Protalix BioTherapeutics, Inc., announced today that additional data from the Company's pivotal Phase III clinical trial of taliglucerase alfa in patients with Gaucher disease was presented at the Annual Meeting of the Lysosomal Disease Network: WORLD Symposium 2010 in Miami, Florida, during an oral session titled, "Novel Enzyme Replacement Therapy for Gaucher Disease: Phase III Pivotal Clinical Trial with Plant Cell Expressed Recombinant Glucocerebrosidase (prGCD) - taliglucerase alfa."
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, announced today that the United States District Court for the Southern District of Florida has ruled that Watson's generic versions of Mucinex®, Mucinex® D and Mucinex® DM (Guaifenesin, Dextromethorphan HBr/ Guaifenesin, and Pseudoephedrine/Guaifenesin) Extended-Release products, do not infringe U.S. Patent No. 6,372,252.
Dr. Reddy's Laboratories Ltd. today announced its unaudited financial results for the third quarter ended December 31, 2009 under International Financial Reporting Standards (IFRS).
› Verified 5 days ago
Mrs. Brittany Herman, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 887 Bridgeport Ave, Shelton, CT 06484 Phone: 203-225-6020 | |
Dr. Saroja Koneswaran, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 21 Huntington Plaza, Shelton, CT 06484 Phone: 203-929-6358 Fax: 203-929-3826 | |
Stephanie J Rowe, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 887 Bridgeport Ave, Shelton, CT 06484 Phone: 203-225-6020 Fax: 203-384-3829 | |
Dr. Kenneth Ward, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 110 Commerce Dr, Shelton, CT 06484 Phone: 203-929-7331 Fax: 203-925-0330 | |
Dr. Fadeke O Longe, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4 Corporate Dr, Shelton, CT 06484 Phone: 203-225-0375 | |
Dr. Bharvi Ashok Balar, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 224 Leavenworth Rd, Shelton, CT 06484 Phone: 203-926-1206 Fax: 203-926-0413 |